Unraveling Mast Cell Activation Syndrome:
Symptoms, Causes, and Diagnostic Challenges
Mast Cell Activation Syndrome (MCAS) is a condition characterized by the inappropriate and excessive activation of mast cells, leading to a wide range of symptoms that can affect multiple organ systems. While MCAS is increasingly recognized in clinical settings, diagnosing the condition remains a significant challenge due to its complex presentation, overlap with other conditions, and variability among patients. The functional medicine approach, which emphasizes patient-centered care, integrative diagnostics, and individualized treatment plans, offers a unique lens through which MCAS can be understood. Here we look at the common symptoms seen in MCAS, the potential causes of MCAS, the test often run to diagnose MCAS, and the specific challenges of diagnosing MCAS, highlighting the limitations of traditional diagnostic criteria and emphasizing the role of holistic and integrative approaches.
Common MCAS Symptoms
Individuals grappling with MCAS frequently contend with persistent and incapacitating fatigue that often proves unresponsive to rest. This leads many people to believe that MCAS is the underlying cause of Chronic Fatigue Syndrome (CFS).
While antihistamines may offer relief by lowering high histamine levels commonly seen in the disorder, conventional pain medications may fall short in effectively managing the widespread body pain associated with MCAS. This symptom is often “diagnosed” as “fibromyalgia.” Sadly, once that label is applied to a person’s personal health record, it never goes away. When doctors hear this label, they switch off their brains and quit looking for the cause. Once a fibro patient, always a fibro patient.
Bloating, abdominal pain, and other gastrointestinal issues manifest as common symptoms of MCAS. These symptoms are generally dismissed after a patient gets an endoscopy and colonoscopy that appear normal. By contrast, integrative health practitioners use a gut bacteriological and parasite test to look further than conventional doctors.)
Heightened sensitivities to various environmental factors, including chemicals, smells, dyes, and fragrances, are observed in individuals with MCAS. Frequent skin manifestations of MCAS include migratory rashes and hives are also common.
Exercise-induced shortness of breath is a prevalent symptom, reflecting the impact of mast cell activation on respiratory function. Episodes of low blood pressure, contributing to dizziness and fainting in some cases, are associated with MCAS.
Another confusing symptom is fluctuating vision problems. These add to the complexity of symptoms experienced by individuals with MCAS. Anxiety, often unrelated to external stressors, is a common neurological symptom associated with MCAS. Both of these symptoms can be directly tied to high histamine levels in the brain.
Challenges in Diagnosing Mast Cell Activation Syndrome
1. Complex and Variable Symptomatology
One of the primary challenges in diagnosing MCAS is its diverse and often inconsistent symptom presentation. Mast cells are found in almost every tissue in the body and can affect multiple organ systems, leading to a wide range of symptoms such as gastrointestinal distress, dermatological issues, cardiovascular symptoms, and neurological complaints. The functional medicine perspective views the body as an interconnected system, and MCAS exemplifies this principle. However, this also complicates the diagnostic process, as patients with MCAS may present with symptoms that mimic other conditions, including irritable bowel syndrome (IBS), fibromyalgia, and chronic fatigue syndrome.
Functional medicine practitioners recognize that patients with MCAS may exhibit “atypical” symptoms, and traditional diagnostic protocols may miss the diagnosis due to the reliance on symptom checklists or rigid criteria. The highly variable nature of symptoms across different patients requires a more personalized approach to diagnosis, one that takes into account the patient’s entire clinical history, environmental exposures, and lifestyle factors.
2. Lack of Standardized Diagnostic Criteria
MCAS remains a poorly defined condition, with no universally accepted diagnostic criteria, which poses a significant challenge for both conventional and functional medicine practitioners. In conventional medicine, a diagnosis of MCAS is often based on clinical suspicion, laboratory tests (such as serum tryptase levels), and the exclusion of other conditions. However, many patients with MCAS may have normal tryptase levels, and their symptoms may fluctuate, making it difficult to capture the biochemical evidence needed for a definitive diagnosis.
From a functional medicine standpoint, this lack of standardized diagnostic criteria underscores the need for a more comprehensive and nuanced diagnostic approach. Functional medicine practitioners may use advanced laboratory testing, including tests for mast cell mediators such as histamine, prostaglandins, and leukotrienes, to gather more data about mast cell activity. However, even these tests are not always reliable or accessible, and their interpretation requires a deep understanding of mast cell biology.
In addition, functional medicine practitioners often look for patterns of inflammation, immune dysregulation, and other underlying triggers that may be contributing to mast cell dysfunction. This systems-oriented approach can help identify root causes that are often missed in conventional diagnostic frameworks, but it also complicates the diagnostic process by introducing additional layers of complexity.
3. Overlapping Conditions and Comorbidities
Many patients with MCAS also suffer from other conditions that share overlapping symptoms, such as Ehlers-Danlos syndrome (EDS), postural orthostatic tachycardia syndrome (POTS), and small intestinal bacterial overgrowth (SIBO). These comorbidities can obscure the diagnosis of MCAS, as the symptoms of one condition may be attributed to another. Functional medicine practitioners, with their focus on identifying underlying imbalances and systemic dysfunctions, are often better equipped to navigate these complex clinical presentations. However, the presence of multiple overlapping conditions makes the diagnostic process time-consuming and requires a careful and integrative approach.
Functional medicine practitioners frequently employ a broader range of diagnostic tools, such as gut microbiome testing, nutrient assessments, and genetic testing, to explore the potential links between MCAS and these comorbidities. While these tools can provide valuable insights, they also increase the complexity of the diagnostic process and the interpretation of results.
4. Environmental and Lifestyle Factors
A key tenet of functional medicine is the recognition of the role that environmental factors, such as toxins, allergens, and infections, play in chronic disease. In the case of MCAS, many patients report symptom flare-ups in response to environmental triggers such as mold, food sensitivities, or chemical exposures. Diagnosing MCAS from a functional medicine standpoint often involves a thorough evaluation of a patient’s environment, diet, and lifestyle to identify potential triggers that could be contributing to mast cell dysregulation.
The functional medicine approach emphasizes the importance of addressing these underlying environmental and lifestyle factors as part of the diagnostic and treatment process. However, identifying and managing these triggers can be a complex and lengthy process, requiring the collaboration of multiple healthcare professionals and a detailed understanding of the patient’s unique context.
5. Psychosocial Considerations and Patient-Doctor Relationship
Functional medicine places a strong emphasis on the patient-doctor relationship, recognizing that chronic and complex conditions such as MCAS require a collaborative and empathetic approach to care. Many patients with MCAS have experienced frustration with the conventional medical system, often being dismissed or misdiagnosed due to the complexity of their symptoms. Functional medicine practitioners aim to foster a more supportive and patient-centered environment, which can help build trust and improve diagnostic accuracy.
However, the psychosocial aspects of MCAS also present challenges. Patients with chronic illness often experience psychological distress, which can exacerbate their symptoms and complicate the diagnostic process. Functional medicine practitioners must be attuned to these psychosocial factors and incorporate them into their diagnostic and treatment plans, which requires time, patience, and a high level of clinical skill.
Hypothesized Causes of Mast Cell Disease
Environmental and food mold exposure is considered a potential trigger for MCAS. Testing for mycotoxins, which can persist in the body for extended periods, may be conducted to identify and address mold-related issues. It is also worth noting that for people with MCAS, detoxing from mold can be harder than it is for the average person.
Various infections, such as Epstein Barr Virus, COVID (leading to Long COVID), Lyme disease, and herpes, have been linked to the development or exacerbation of MCAS.
Conditions With Similar Symptoms:
Small Intestinal Bacterial Overgrowth (SIBO) may present with symptoms like gas and bloating, resembling those of MCAS. Distinguishing between the two is crucial for accurate diagnosis and appropriate treatment.
MCAS may be mistaken for histamine intolerance, where the body lacks sufficient diamine oxidase (DAO) to break down histamines. Understanding the differences is vital for effective management.
Common Tests for MCAS
- Testing for elevated histamine levels can indicate mast cell activation.
- N-Methyl-Histamine levels, another marker for mast cell activation, are often assessed in conjunction with histamine levels.
- Elevated levels of tryptase, although more commonly associated with mastocytosis, can sometimes be observed in MCAS during flare-ups.
- Measuring prostaglandin D2 levels helps assess the inflammatory response associated with MCAS.
- Elevated chromogranin A levels may indicate mast cell activation and are included in the battery of tests for MCAS diagnosis.
Other Relevant Tests
Functional medicine tests, such as the Organic Acids Test, can help reveal various other causes and complicating factors for MCAS. Likewise, the Omega-3 test can show elevated levels of inflammation which are common in people with MCAS. The Hair Mineral Tissue Analysis test can also help to identify which minerals may be lacking or exist in toxic levels as well as heavy metals that may be hiding out in the system.
Mast Cell Activation Syndrome poses a significant challenge, necessitating a comprehensive understanding of its diverse symptoms and potential triggers. Achieving accurate diagnosis involves differentiating MCAS from other conditions with similar presentations and conducting specific tests to identify mast cell activation. As research progresses, a multidisciplinary approach involving healthcare professionals from various specialties becomes crucial for managing and enhancing the quality of life for individuals with MCAS.
References
- Afrin, Lawrence B., et al. “Diagnosis of Mast Cell Activation Syndrome: A Multidisciplinary Approach.” Journal of Allergy and Clinical Immunology, vol. 144, no. 3, 2019, pp. 728-738. https://www.jacionline.org/article/S0091-6749(19)30968-3/fulltext.
-
Theoharides, Theoharis C., et al. “Mast Cells, Tryptase, and Inflammation in Systemic Disease.” Nature Reviews Immunology, vol. 17, 2017, pp. 265-278. https://www.nature.com/articles/nri.2017.23.
-
Molderings, Gerhard J., et al. “Understanding Mast Cell Activation Disorders.” National Institutes of Health, 2020. https://pubmed.ncbi.nlm.nih.gov/32478719/.
-
Akin, Cem, et al. “Mast Cell Activation Syndrome: Proposed Diagnostic Criteria.” Journal of Allergy and Clinical Immunology, vol. 128, no. 4, 2011, pp. 727-732. https://pubmed.ncbi.nlm.nih.gov/21839130/.
-
Institute for Functional Medicine. “Mast Cell Activation Syndrome.” https://www.ifm.org/news-insights/mast-cell-activation-syndrome/
-
Valent, Peter, et al. “Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome.” Journal of Allergy and Clinical Immunology: In Practice, vol. 7, no. 4, 2019, pp. 1125-1133. https://pubmed.ncbi.nlm.nih.gov/30677517/.
-
Hamilton, Matthew J., et al. “Mast Cell Activation Syndrome: An Emerging Clinical Challenge in Allergy and Immunology.” Journal of Allergy and Clinical Immunology, vol. 143, no. 6, 2019, pp. 2000-2007. https://www.jacionline.org/article/S0091-6749(19)30523-1/fulltext.
-
Valent, Peter, et al. “Mast Cell Activation Syndromes: Current Classification and Future Prospects.” Journal of Allergy and Clinical Immunology, vol. 140, no. 3, 2017, pp. 771-780. https://pubmed.ncbi.nlm.nih.gov/28343852/.
-
Frye, Richard E., et al. “Mast Cell Activation and Autism Spectrum Disorder: The Role of the Gut-Brain Axis.” Frontiers in Neuroscience, vol. 13, 2019. https://www.frontiersin.org/articles/10.3389/fnins.2019.00394/full.
-
Castells, Mariana, et al. “Mast Cell Activation Disorder and Anaphylaxis.” Immunology and Allergy Clinics of North America, vol. 37, no. 1, 2017, pp. 153-164. https://pubmed.ncbi.nlm.nih.gov/27986592/.
-
Li, Z., et al. “Small Intestinal Bacterial Overgrowth and Its Relationship to Irritable Bowel Syndrome Symptoms.” World Journal of Gastroenterology, vol. 23, no. 32, 2017, pp. 5835-5840. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556543/.
-
Dempsey, Thais T., et al. “Environmental Triggers in Mast Cell Activation Disorders.” Annals of Allergy, Asthma & Immunology, vol. 123, no. 5, 2019, pp. 451-457. https://pubmed.ncbi.nlm.nih.gov/31281026/.